Form 144: Wolverine World Wide insider sale of 53,079 shares valued $1.44M
Rhea-AI Filing Summary
Wolverine World Wide, Inc. is the issuer named in this Form 144 notice reporting a proposed sale of common stock on the NYSE. The filer reports 53,079 shares to be sold through Merrill with an aggregate market value of $1,441,649 against 81,254,351 shares outstanding, and lists an approximate sale date of 08/08/2025. The securities scheduled for sale were acquired through multiple restricted stock vesting events recorded between 02/09/2022 and 08/02/2025, with individual vesting lots shown in the filing. The filing states there were no securities sold by the person in the past three months. Several recent vesting lots (for example, 14,652 shares on 10/30/2024 and 8,121 shares on 02/09/2025) are listed as sources of the shares to be sold.
Positive
- Securities to be sold were acquired via restricted stock vesting, indicating they stem from compensation rather than new outside purchases
- No securities sold in the past three months by the person for whose account the securities are to be sold
Negative
- None.
Insights
TL;DR: Routine insider sale of vested restricted shares; size is immaterial relative to outstanding stock.
The Form 144 documents a proposed sale of 53,079 shares with an aggregate value of $1,441,649. These shares were acquired via multiple restricted stock vesting events between 2022 and 2025, indicating compensation-related origin rather than open-market purchases. At ~0.065% of the issuer's stated 81,254,351 outstanding shares, the lot size is small and unlikely to be material to valuation or control. The filing also reports no sales in the past three months by the reporting person.
TL;DR: Disclosure aligns with Rule 144 requirements; transaction appears procedural following vesting.
The notice details the nature of acquisition as restricted stock vest across multiple dates and includes broker information (Merrill). The filing contains the required representation regarding material nonpublic information. No unusual aggregations or past three-month sales are reported. From a governance perspective, this reads as a routine compliance filing related to employee or executive compensation vesting and subsequent planned sale.